Publicaciones en las que colabora con MARIA VICTORIA GONZALEZ MEANA (9)

2018

  1. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

  2. TP53 p.R72P genotype is a marker of poor prognosis in lung cancer

    Cancer Biomarkers, Vol. 21, Núm. 4, pp. 747-754

2016

  1. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793

2014

  1. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors

    BMC Cancer, Vol. 14, Núm. 1

2013

  1. Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors

    American Journal of Clinical Pathology, Vol. 140, Núm. 1, pp. 61-72

2010

  1. Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients

    BMC Cancer, Vol. 10

  2. Snail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumors

    Lung Cancer, Vol. 69, Núm. 3, pp. 289-295

2008

  1. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: Prognostic implications

    Oncology Reports, Vol. 20, Núm. 3, pp. 589-595

2007

  1. Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin

    British Journal of Cancer, Vol. 97, Núm. 2, pp. 201-209